Tilray.jpg

Tilray researches, cultivates, processes and globally distributes medical cannabis.  Tilray supplies high-quality cannabis products to tens of thousands of patients in ten countries on five continents.

E Squared Invested in Series A preferred shares in January 2018 at a $600 million valuation. Tilray went public on NASDAQ on 7/18/2018 at a $1.63B valuation. 


juul-copy-600x315-0.jpg

E Squared invested in Juul Series D preferred shares in January 2017 at a $207 million valuation. Most recent capital raised at a $16B valuation.


PAX_Labs_Logo_2017.png

Twist_Bioscience_Official_Logo.png

25412f5fd5bb185183c3f9e063b7.jpg